AI medical decision support

A research project at The Robert Gordon University in Aberdeen is using artificial intelligence to assist physicians in treating prostate cancer.

Prostate cancer is the most widespread type of cancer affecting men and the second most common cause of terminal cancer in the UK.

Despite the prevalence of the disease, very little is known about its direct causes and deciding on a disease management plan for a patient can be difficult.

To address this, a research project being undertaken by the School of Computing at the Robert Gordon University (RGU) in Aberdeen is using artificial intelligence to assist physicians in making their decision.

On diagnosis of prostate cancer, recovery greatly depends on the stage of the disease and the health status of the patient. Therefore, early diagnosis and an appropriate management plan taking into account the health of the patient are vital to both survival and quality of life.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox